Insight Into Mouse Models of Hyperthyroidism.

Area of Science:

• Endocrinology
• Immunology
• Ophthalmology

Background:

• Hyperthyroidism involves excess thyroid hormone synthesis, commonly caused by Graves' disease (GD).
• Established mouse models facilitate research into hyperthyroidism and GD.
• Current GD induction methods include genetic manipulation and hormone supplementation.

Purpose of the Study:

• To explore novel therapeutic strategies for Graves' disease (GD) and Graves' orbitopathy (GO) using established mouse models.
• To identify new treatment targets and alternative therapies for GD and GO.

Main Methods:

• Induction of GD in mouse models via various methods.
• Prophylactic administration of TSHR A subunit protein.
• Treatment with ICAM-1 mAb and siRNA targeting TSHR.
• Identification of therapeutic targets in GO mouse models.

Main Results:

• Prophylactic TSHR A subunit protein demonstrated immune tolerance and protection against GD development.
• ICAM-1 mAb and TSHR-targeting siRNA showed efficacy in treating GD.
• New therapeutic targets were identified in GO mouse models, suggesting novel treatment approaches.

Conclusions:

• Mouse studies have identified promising novel treatments for Graves' disease and Graves' orbitopathy.
• Potential alternative therapies like hPMSCs, fucoxanthin, and icariin warrant further investigation for GD and GO.